| Name | Title | Contact Details |
|---|
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
The Federal Reserve Board, commonly known as the Fed, is the central authority of the Federal Reserve System, which serves as the central banking system of the United States. Established in 1913, the Fed aims to create a stable monetary system and address banking panics. Headquartered in Washington, D.C., it oversees 12 regional Federal Reserve Banks, balancing regional insights with national policy. The Fed has five main functions: conducting monetary policy to promote maximum employment and stable prices, ensuring financial system stability, supervising and regulating financial institutions, fostering efficient payment and settlement systems, and promoting consumer protection and community development. It also provides essential services such as payment processing and economic data publications, including the Beige Book and the FRED database. The Fed plays a crucial role in supporting the U.S. economy and serves various stakeholders, including depository institutions, the U.S. government, and foreign official institutions.
Electrify America, LLC is a prominent electric vehicle (EV) charging network in the United States, established in 2016 as a subsidiary of Volkswagen Group of America. The company aims to promote Zero-Emission Vehicle (ZEV) adoption by creating a nationwide network of ultra-fast and convenient EV charging stations. As of August 2024, Electrify America operates over 950 charging stations with more than 4,250 DC fast charging connectors, making it the largest open DC fast-charging network in the country. The company focuses on providing reliable and accessible hyper-fast charging solutions, supporting multiple connector types, including CCS and CHAdeMO, with plans to add Tesla’s North American Charging Standard (NACS) connectors in 2025. Electrify America is committed to sustainability, ensuring that all energy supplied to drivers is backed by 100% renewable energy certificates, and aims for a net zero carbon footprint. Headquartered in Reston, Virginia, the company employs around 300 people and actively engages in community education to promote equitable electrification.
Delinea is an ISO 9001:2015 certified CNC manufacturing company which specializes in 3+2 positional and 3 axis precision milling. Founded in 2019 by Vincent and Dan Krische, Delinea is based out of a 4,800 square foot facility in Loveland Colorado. Featuring state-of-the-art equipment and automated software we provide the crucial digital manufacturing service that you need in order to become top of your industry and a leader in innovation.